Germany STD diagnostics market is growing at a CAGR of around 7.9% during the forecast period. Germany STD diagnostics market is growing due to the factors including the most important of which is the government support towards health of the public. Health insurance is one of the major guidelines enforced by government of Germany.
Visit for Global Sexually Transmitted Diseases (STD)
Diagnostics Market Report at: https://www.omrglobal.com/industry-reports/sexually-transmitted-disease-market-size
Health insurance is mandatory for all citizens and permanent residents of Germany. It is provided by two systems, that is competing, not-for-profit, nongovernmental health insurance funds in the statutory health insurance (SHI) system and substitutive private health insurance (PHI). States own most university hospitals, while municipalities play a role in public health activities and own about half of all hospital beds. Though, the various levels of governments have virtually no role in the direct financing or delivery of health care, these health insurances insure the people of any critical illness such as cancer, STDs and so on, which is anticipated to influence the growth of the Germany STD diagnostics market during the forecast period.
Syphilis is a type of STIs contracted through sexual contact and as from mother to child at birth. The country’s Syphilis average was more than 7.1 cases for every 100,000 residents. Syphilis prevalence among MSM has been on the rise during the last few years. Further, HIV treatment has been made available in Germany for preventing the onset of AIDS and enabling people with HIV to live longer and healthier lives.
However, it is estimated that more than 1000 people in Germany every year develop AIDs due to late diagnosis or due to inability to have an access to the treatment. The Kein AIDS für Alle campaign has been launched in Germany to remove the stigma and discrimination around HIV and encouraging key populations to have an access to HIV prevention, testing, treatment and care services through innovative initiatives. The support will be provided to the doctors for improving the timely diagnosis of HIV, and in turn affects the Germany STD diagnostics market.
Research Methodology
The market study of the Germany STD Diagnostics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Germany STD Diagnostics Market by Disease Type
5.1.1. Chlamydia
5.1.2. Syphilis
5.1.3. Gonorrhea
5.1.4. Herpes Simplex Virus (HSV)
5.1.5. Human Papilloma Virus (HPV)
5.1.6. Human Immunodeficiency Virus (HIV)
5.1.7. Others
5.2. Germany STD Diagnostics Market by Product
5.2.1. Laboratory Testing Devices
5.2.2. Point-of-Care (POC) Testing Devices
5.3. Germany STD Diagnostics Market by End-user
5.3.1. Hospitals and Clinics
5.3.2. Diagnostic Centers
5.3.3. Homecare
6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.2. AbbVie Inc.
6.3. Becton, Dickinson and Co.
6.4. Biocartis NV
6.5. Bio-Rad Laboratories, Inc.
6.6. Danaher Corp.
6.7. Eli Lilly and Co.
6.8. F. Hoffmann-La Roche Ltd.
6.9. Merck KGaA
6.10. Thermo Fisher Scientific, Inc.
1. GERMANY STD DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2018-2025 ($ MILLION)
2. GERMANY STD DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
3. GERMANY STD DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
1. GERMANY STD DIAGNOSTICS MARKET SHARE BY BIOMARKER DISEASE TYPE, 2018 VS 2025 (%)
2. GERMANY STD DIAGNOSTICS MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)
3. GERMANY STD DIAGNOSTICS MARKET SHARE BY END-USER, 2018 VS 2025 (%)